How to prevent the microvascular complications of type 2 diabetes beyond glucose control
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Microvascular complications (retinopathy, nephropathy, and neuropathy) affect hundreds of millions of patients with type 2 diabetes. They usually affect people with longstanding or uncontrolled disease, but they can also be present at diagnosis or in those yet to have a diagnosis made. The presentation and progression of these complications can lead to loss of visual, renal, and neurologic functions, impaired mobility and cognition, poor quality of life, limitations for employment and productivity, and increased costs for the patient and society. If left uncontrolled or untreated, they lead to irreversible damage and even death. This review focuses on the primary and secondary prevention of diabetic microvascular complications in patients with type 2 diabetes, beyond glycemic control. Interventions discussed include standard of care interventions supported by guidelines from major organizations, as well as additional proposed interventions that are supported by research published in the past decade. High level evidence sources such as systematic reviews and large, multicenter randomized clinical trials have been prioritized. Smaller trials were included where high quality evidence was unavailable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Wan, H., Wang, Y., Xiang, Q., Fang, S., Chen, Y., Chen, C., Zhang, W., Zhang, H., Xia, F., Wang, N., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01095-4 · Cited by 306
Mora, J. C., & Valencia, W. M. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.08.007 · Cited by 196
Self-citationGeorge, C., Echouffo-Tcheugui, J. B., Jaar, B. G., Okpechi, I. G., & Kengne, A. P. (2022) · BMC Medicine · doi:10.1186/s12916-022-02438-6 · Cited by 91
“Due to the lack of awareness, opportunities to prevent adverse outcomes of CKD are severely limited [22] and many people with diabetes progress to kidney failure or succumb due to CVD complications [5, 23, 24].”
BackgroundDevice and method for noninvasive glucose assessment
Segman, Y. (. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818763457 · Cited by 55
He, F., Ng Yin Ling, C., Nusinovici, S., Cheng, C.-Y., Wong, T. Y., Li, J., & Sabanayagam, C. (2024) · Journal of Medical Internet Research · doi:10.2196/41065 · Cited by 29
Metadata
- Authors
- Valencia, W. M., & Florez, H.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2017-01-17
- Volume
- 356
- Pages
- i6505
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2572896393
- Cited by
- 233
- References
- 1
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.